Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lun Xi Liang"'
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Here, we aimed to compare the effects of different preservation methods on outcomes of fecal microbiota. We evaluated the effects of different preservation methods using stool sample preservation experiments for up to 1 year. The stool sampl
Externí odkaz:
https://doaj.org/article/712952fb717d42e39bd14897c08ff48b
Autor:
Ji-Lin Wang, Chun-Rong Guo, Tian-Tian Sun, Wen-Yu Su, Qiang Hu, Fang-Fang Guo, Lun-Xi Liang, Jie Xu, Hua Xiong, Jing-Yuan Fang
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Splicing factor SRSF3 is an oncogene and overexpressed in various kinds of cancers, however, the function and mechanism involved in colorectal cancer (CRC) remained unclear. The aim of this study was to explore the relationship be
Externí odkaz:
https://doaj.org/article/b33c45ae4ccb4145965478d540b562ed
Autor:
Lun Xi Liang, Huan Bin Wang, Chu Shu Li, Ying Xuan Chen, Yao Zhang, Jing-Yuan Fang, Han Yao, Jie Xu
Publikováno v:
Journal of Digestive Diseases. 18:574-581
Programmed death-ligand 1 (PD-L1) expression in colorectal cancers (CRCs) was implicated in predicting anti-PD-1/PD-L1 therapy efficacy. However, therapeutic response has also been found in patients without PD-L1 expression in the primary tumor. Here
Autor:
Huan Bin, Wang, Han, Yao, Chu Shu, Li, Lun Xi, Liang, Yao, Zhang, Ying Xuan, Chen, Jing-Yuan, Fang, Jie, Xu
Publikováno v:
Journal of digestive diseases. 18(10)
Programmed death-ligand 1 (PD-L1) expression in colorectal cancer (CRC) was implicated in predicting anti-PD-1/PD-L1 therapy efficacy. However, therapeutic response has also been found in patients without PD-L1 expression in the primary tumor. In the